Activity Survey

The APBMT Activity Survey has been performed since 2007.
The following figure shows how the data was collected.

Data collection.png

The way of submission is different in each country/region.
From the countries/regions which have a national registry, data is submitted through the national registries. From the countries/regions which do not have a national registry, data is submitted through the regional persons in charge who collect data from major transplant centers or through major transplant centers directly.

 

Participating Countries.png

 

The result of Activity Survey 2019 (HSCT performed in 2017)

1.Total number of SCTs.png

The No. of HSCTs are increasing year by year.

In 2017, that exceeded twenty one thousand in Asia - Pacific region.

 

 

2.Number of HSCTs and centers.png

20 countries/regions and seven-handred-thrirty-three centers cooperated with our Activity Survey.

We appreciate about 40 cooperators made effort collecting this survey.

 

3.All HSCTs by country (over 1000 HSCTs）.png

 

4.All HSCTs by country (100-1000 HSCTs).png

 

5.All HSCTs by country(under 100 HSCTs).png

 

In 2017, Australia:1789, Bangladesh:15, China:6979, HongKong:145, India:2034, Iran:382, Japan:5794, Korea:2626, Malaysia:301, Mongolia:3, Myanmar:8, Nepal:7, NewZealand:280, Pakistan:168, Philippines:10, Singapore:208, SriLanka:11, Taiwan:437, Thailand:209, and Vietnam:91 HSCTs performed.

6.Main indications.png

The pie chart showing the Main indication of HSCTs in Asia-Pacific area.

AML accounts for more than 23 %, Plasma Cell Disorder: 17%, Lymphoid malignancy: 16%, and  ALL : 14%. These top 4 indication accounts three fourth of the whole.

7.Disease types year by year (over 1000).png

The top 6 disease indications are AML, Lymphoid malignancy, Multiple Myeloma, ALL, MDS, and Aplastic anemia. 

 

8.Disease types year by year (100 - 1000).png

9.Disease types year by year (under 100).png

 

10.Major division of disease types by country.png

 

11.Trends in HLA-haploidentical.png

No. of Haplo transplant increased rapidly. In 2017, the number of them run up to 4,143.

 

12.Proportion of Haplo in the related transplant by country.png

Haplo transplant were performed in many countries.

In China, Myanmar, Nepal, and Philippines, Haplo transplant accounts for more than half of related transplant..

 

 

13.Number of total transplants per 10 million population (2017).png

 

0.1-100     Bangladesh, China, India, Malaysia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam

100-300    Hong Kong, and Taiwan

300-500    South Korea, Singapore, and Japan

more than 500    Australia, and New Zealand

 

14.Number of allogeneic transplants per 10 million population (2017).png

0.1-50     Bangladesh, China, India, Iran, Malaysia, Mongolia, Myanmar, Nepal, Pakistan, Philippines, Sri Lanka, Thailand, and Vietnam

50-150    Hong Kong, and Taiwan

150-200    Singapore

more than 200    Australia, Japan, New Zealand, and South Korea 

 

 

15.Number of autologous transplants per 10 million population (2017).png

0-1     Bangladesh, and Philippines

1-50    China, Iran, India, Malaysia, Mongolia, Myanmar, Nepal, Pakistan,Sri Lanka, Thailand, and Vietnam

50-150    Hong Kong, and Taiwan

150-300  Japan, Singapore, and South Korea

more than 300    Australia, and New Zealand

 

 

16.Number of unrelated transplants per 10 million population (2017).png

no UR     Bangladesh, Mongolia, Myanmar, Nepal, Pakistan, and Philippines

0.01-10    China, Iran, India, Malaysia, Sri Lanka, Thailand, and Vietnam

10-50    Taiwan

50-100   Singapore, and Hong Kong

more than 100    Australia, Japan, New Zealand, and South Korea

 

 

Detailed information of APBMT Activity Survey 2016 (PDF). :Members only; need ID, and Password